Yutaka Niihara, Chairman and CEO at Emmaus Life Sciences, Inc. (EMMA), bought 53,800 shares at $1.49 ($80K) on 2022-02-28, disclosed to the SEC on 2022-03-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |